Project Grant R01MH140784
- This Project Grant award from the National Institute on Aging (NIA), funded under the Aging Research program (CFDA 93.866), will support a study to examine the impacts of HIV stigma and gender-based stigma on cognitive function among older women living with HIV/AIDS (WLWH) in the United States. The $146,922 award, with a performance period from January 25, 2025 to July 31, 2025, will leverage data from the longitudinal Women's Interagency HIV Study (WIHS) to investigate whether social support...
- The National Institute of Mental Health (NIMH) awarded a $733,355 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Alabama at Birmingham (UAB) to evaluate social brain health in people living with HIV. The project, titled "Evaluating Social Brain Health in HIV: An RDoC-Based Approach," will investigate the complex set of social cognitive abilities, including recognizing social cues and inferring others' mental states, which are crucial...
- The National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), awarded a $191,117 project grant to The Regents of the University of California, San Francisco (UCSF) to develop and pilot an anti-stigma intervention aimed at improving personalized communication between pharmacy staff and individuals seeking pre-exposure prophylaxis (PrEP) for HIV prevention. The overarching goal is to adapt an existing effective anti-stigma intervention to the U.S....
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will test the impact of a Basic Income Guarantee (BIG) program on viral suppression and clinic engagement for young people living with HIV in Chicago. The $819,998 award will: 1) Provide $500 monthly payments through a randomized controlled trial comparing BIG recipients to a treatment-as-usual group; 2) Assess the effects of BIG on viral suppression, clinic engagement, income...
- This federal Project Grant award, totaling $745,822.00 and provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to investigate the role of the PERK kinase in HIV-induced neuroinflammation and neurocognitive impairment (NCI) in people with HIV (PWH). The University of Pennsylvania, as the primary grantee, will use biochemical, cellular, and pharmacologic approaches to assess PERK's potential as a predictive...
- This federal Project Grant award, titled "Aligning HIV Services with Gender Diverse Community Priorities Through Person-Centered Care: A Mixed Methods Study in India", is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $146,922 award will support a mixed-methods study to explore how a person-centered care model can improve HIV testing engagement and service access for transgender and gender diverse (TGD)...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $126,042 to Duke University to conduct a mixed methods study on intersectional discrimination and sexual health among young Black men who have sex with men (YBMSM). The research aims to identify subgroups of YBMSM with different patterns of intersectional discrimination experiences and determine the relationship between these experiences and sexual...
- This Project Grant award of $198,854 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports a study to measure social isolation, loneliness, and stigma experienced by older adults living with HIV who use methamphetamine. The research will characterize trajectories of social isolation and loneliness over 12 months, and explore patient perspectives on how...
- The National Institute of Mental Health (NIMH) awarded a $3,613,504 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the Icahn School of Medicine at Mount Sinai (ISMMS) on September 22, 2025. This 4-year grant aims to investigate the role of the NLRP3 inflammasome in HIV-induced neuroinflammation and its impact on HIV persistence in the central nervous system (CNS). The project has three key objectives: 1) Elucidate the link between HIV-1 infection and NLRP3...
- This Project Grant award, totaling $1,243,071.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant will fund the development of a new collaborative eligibility platform by Groupware Technologies, LLC (UEI: E8T9F94UU7D4) to support the application, determination, recertification, and enrollment processes for the Ryan White HIV/AIDS Program (RWHAP). The platform aims to increase linkage to care and retention...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to optimize measurement and evaluate the health impacts of social, behavioral, and economic (SBE) stigmas among populations at risk for and living with HIV in the U.S. The $733,314 award will leverage the PLHIV Stigma Index 2.0 platform to collect attributional and non-attributional SBE stigma data, as well as qualitative data, across geographically and demographically varying sites. The project will improve stigma measurement tools, assess their validity and measurement invariance, and describe health outcomes associated with layered SBE stigmas. This research aims to better characterize the effects of SBE stigmas on the health of people living with HIV and develop strategies to bolster the use of stigma data in the HIV response. The award period runs from September 2025 through August 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $733.3k | 9/23/25 |